Nanyang Biologics, NVIDIA, HPE & Equinix to launch AI drug discovery platform
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
The FDA is beginning rulemaking to close the “adequate provision” loophole
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Subscribe To Our Newsletter & Stay Updated